Sign Up Today and Learn More About Evommune Stock
Invest in or calculate the value of your shares in Evommune or other pre-IPO companies through EquityZen's platform.
Evommune Stock (EVOM)
Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.
About Evommune Stock
Founded
2020
Headquarters
Palo Alto, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Evommune Press Mentions
Stay in the know about the latest news on Evommune
Evommune: $115 Million (Series C) Secured To Advance Clinical-Stage Pipeline Addressing Chronic Inflammatory Diseases
pulse2 • Nov 08, 2024
Evommune Announces $115 Million Series C
vcnewsdaily • Nov 05, 2024
RTW Biotech invests in inflammation treatment firm Evommune
marketscreener • Nov 04, 2024
Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight
globenewswire • Nov 04, 2024
Financings for Nov. 1, 2024
bioworld • Nov 02, 2024
Evommune Management
Leadership team at Evommune
Co-Founder & Chief Medical Officer
Eugene A. Bauer
Chief Corporate Strategy and Legal Officer
Greg Moss
Join now and verify your accreditation status to gain access to:
- Evommune current valuation
- Evommune stock price
- Available deals in Evommune and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Evommune stock?
Accredited investors can buy pre-IPO stock in companies like Evommune through EquityZen funds. These investments are made available by existing Evommune shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Evommune stock?
Shareholders can sell their Evommune stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
